Table 1.
All | High-risk HPVa seropositive | High-risk HPV seronegative | |||||
---|---|---|---|---|---|---|---|
Characteristic | Cases (n=959) | Controls (n=1208) | P value | Cases (n=525) | P valueb | Cases (n=296) | P value |
Sex | |||||||
Female | 258(26.9) | 323(26.7) | 0.93c | 121 (23.0) | 0.11 | 86 (29.0) | 0.42c |
Male | 701(73.0) | 885(73.2) | 404 (76.9) | 210(70.9) | |||
Race/Ethnicity | |||||||
Caucasian | 871(90.8) | 1,090(90.2) | 0.59c | 487 (92.7) | 0.05 | 272(91.8) | 0.30c |
Non-Caucasian | 87(9.0) | 118(9.7) | 38 (7.2) | 23 (7.7) | |||
Age | |||||||
0-40 | 31(3.2) | 38(3.1) | 0.02b | 11 (2.0) | 0.001 | 16(5.4) | 0.45b |
40-50 | 131(13.6) | 133(11.0) | 78(14.8) | 38(12.8) | |||
50-60 | 324(33.7) | 384(31.7) | 192 (36.5) | 89(30.0) | |||
60-70 | 294(30.6) | 389(32.2) | 167 (31.8) | 87(29.3) | |||
≥70 | 179(18.6) | 264(21.8) | 77(14.6) | 66(22.2) | |||
Education | |||||||
High School | 401(41.8) | 340(28.1) | <.0001c | 194 (36.9) | 0.001 | 138(46.6) | <.0001c |
College | 378(39.4) | 551(45.6) | 209 (39.8) | 114(38.5) | |||
Professional School | 167(17.4) | 288(23.8) | 111 (21.1) | 43(14.5) | |||
BMI | |||||||
18.5-25 | 325(33.8) | 360(29..8) | <0.01c | 154 (29.3) | 0.22 | 119 (40.2) | <0.001c |
25-30 | 421(43.8) | 504(41.7) | 240 (45.7) | 124 (41.8) | |||
≥30 | 213(22.2) | 344(28.4) | 131 (24.9) | 53(17.9) | |||
Alcohol | |||||||
First quartile | 173(18.0) | 302(25.0) | <.0001b | 98 (18.6) | <.0001 | 51 (17.2) | <.0001b |
Second quartile | 152(15.8) | 300(24.8) | 86 (16.3) | 43 (14.5) | |||
Third quartile | 189(19.7) | 302(25.0) | 121 (23.0) | 46 (15.5) | |||
Forth quartile | 442(46.0) | 301(24.9) | 219 (41.7) | 154(52.0) | |||
Smoking Statusd | |||||||
Never | 236(24.6) | 486(40.2) | <.0001c | 158 (30.0) | <.0001 | 52 (17.5) | <.0001c |
Former | 596(62.1) | 557(46.1) | 317 (60.3) | 190 (64.1) | |||
Current | 116(12.0) | 152(12.5) | 42(8..0) | 52 (17.5) | |||
Smoking | |||||||
Never | 236(24.6) | 486(40.2) | <.0001b | 158 (30.0) | <0.001 | 52 (17.5) | <.0001b |
Moderatee | 221(23.0) | 293(24.2) | 138(26.2) | 52 (17.5) | |||
Heavyf | 502(52.3) | 429(35.5) | 229(43.6) | 192 (64.8) | |||
Tumor Site | |||||||
Laryngeal | 153(15.9) | 67 (12.7) | 64(21.6) | ||||
Oral cavity | 353(36.8) | 149(28.3) | 144 (48.6) | ||||
Pharyngeal | 440(45.8) | 305(58.0) | 84 (28.3) | ||||
Tumor Stage | |||||||
I | 131(13.6) | 49 (9.3) | 64 (21.6) | ||||
II | 124(12.9) | 53(10.0) | 47(15.8) | ||||
III | 153(15.9) | 86(16.3) | 44(14.8) | ||||
IV | 485(50.5) | 319(60.7) | 115(38.8) |
High-risk HPV include HPV16, 18, 31, 33, 45, 52, 58.
Spearman test for continuous variables and chi-square test for categorical variables.
Chi-square test for categorical variables.
Former (not smoking at time of interview) and current smokers (smoking at time of interview) reported having ever smoked 100 cigarettes or more (five packs) in their lifetime; if they had not, they were considered to be never smokers.
Moderate smoker was defined as those who smoke but less than 20 pack years.
Heavy smoker is defined as those who smoke more than 20 pack years.